Donate

Blog Grid

Berkeley Conference | A Call for Action
03 Sep 2018

Berkeley Conference | A Call for Action

Nontuberculous mycobacteria (NTM) are not only conventional opportunistic pathogens, but they are important sources of triggers of chronic immune-mediated and autoimmune disorders. In this short note and associated paper, Dr. Karel Hruska highlights the risk posed by NTM in water, food, and soil. Hence NTM are associated with the so called “civilization diseases” (Type 1 diabetes, Crohn’s disease, multiple sclerosis, asthma, psoriasis, rheumatoid arthritis, and others.)

in 2018 Berkeley, News
Cardiac Sarcoidosis Patient Healed by Anti-MAP Antibiotics
26 Aug 2018

Cardiac Sarcoidosis Patient Healed by Anti-MAP Antibiotics

The author of this recent case study, Branko G. Celler, an Emeritus Professor at the University of New South Wales in Sydney, Australia, developed a particularly serious form of sarcoidosis in 2012. While sarcoidosis is a chronic disease characterized by the formation of granulomas in various organs, only a small portion of patients have cardiac involvement, which can lead to symptomatic conduction disturbances, ventricular arrhythmias, progressive heart failure and sudden death. Read more about his recovery with anti-mycobacterial antibiotics.

in News
Berkeley Conference in September: Updates and Registration
06 Aug 2018

Berkeley Conference in September: Updates and Registration

Have you reserved your spot for the Human Para Conference, Mycobacterial Implications in Crohn’s and Chronic Inflammatory Diseases, coming to Berkeley, CA on September 21st & 22nd? It’s not too late! Registration closes a week prior to the event, and a detailed agenda, abstracts and updated registration information have recently been added to the conference pages. Additionally, we are pleased to announce that portions of this activity have been approved for AMA PRA Category 1 CreditTM.

in News
2017 Annual Report
04 Aug 2018

2017 Annual Report

The 2017 Human Paratuberculosis Foundation annual report is now available. Read about our first year in review, including a financial update.

in News
Joint MAP Testing Study Comes to NYC
19 Jul 2018

Joint MAP Testing Study Comes to NYC

Two new dates have been added to the Joint MAP Testing Study! Dr. Stuart Weg and Dr. J. Todd Kuenstner will draw the final 45 samples needed to complete Human Para’s inaugural MAP research project in August. If you are over the age of 18 and live in the New York City area, please consider participating in our study, either as a Crohn’s disease patient or a healthy control. We are seeking 15 Crohn’s patients and 30 healthy control subjects to donate a small amount of blood.

in News